1197P First-line lorlatinib versus crizotinib in ALK-positive non-small cell lung cancer: Asian subgroup analysis of CROWNQin Zhou, H.R. Kim,Ross A. Soo,G-C. Chang,C-H. Chiu,Hidetoshi Hayashi,S.-B. Kim,Shunsuke Teraoka,Yasushi Goto,Jiaojiao Zhou,Victor Ho-Fun Lee,Baohui Han,James Chung-Man Ho,D-W. Kim,C-C. Lin, Shuliang Lu,Anna Polli, A.M. Calella,Tony Mok,Y-L. WuAnnals of Oncology(2021)引用 1|浏览2暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要